05:01:16 EDT Thu 03 Jul 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Treatment.com AI Inc
Symbol TRUE
Shares Issued 75,502,398
Close 2025-06-10 C$ 0.35
Market Cap C$ 26,425,839
Recent Sedar Documents

Treatment.com releases new version of MES

2025-06-11 10:03 ET - News Release

Dr. Essam Hamza reports

TREATMENT.COM AI ANNOUNCES NEW MEDICAL EDUCATION SUITE TO ENHANCE CLINICAL SKILLS TRAINING THROUGH AI-SIMULATED PATIENTS

Treatment.com AI Inc. has released its latest version of the Medical Education Suite (MES). The University of Minnesota Medical School has successfully completed a live deployment of Treatment.com AI's new Medical Education Suite (MES), an artificial-intelligence-powered clinical skills assessment platform designed to support medical schools in delivering scalable, rigorous and cost-effective objective structured clinical examinations (OSCEs).

The deployment, conducted with over 240 third-year medical students, marked the first large-scale implementation of computer-simulated patient cases developed through the Global Library of Medicine (GLM), a clinician-built medical knowledge engine. The exams ran with complete technical reliability during deployment as well as integrated seamlessly into the school's existing OSCE workflow.

"Our goal is to support medical schools by applying our clinical experience and AI expertise to real educational challenges," stated Dr. Kevin Peterson, founder and chief medical officer of Treatment.com AI. "The Medical Education Suite reflects years of development in diagnostic reasoning and knowledge engineering. By introducing structured, AI-simulated patients alongside live simulated patients and offering objective real-time scoring, we're helping students build stronger clinical skills in the classroom and giving educators the trusted health care education software needed to teach and assess clinical content and behavioural approaches to complex clinical problems with confidence."

The MES is a scalable platform designed to reduce administrative and faculty time, improve objectivity, increase evaluation consistency, and provide a robust digital infrastructure to support both live and AI-simulated formats. The focus of the platform is to help enhance the clinical skills of the next generation of health care professionals. By incorporating curated AI-generated cases and the supportive services provided by Treatment.com, the system enables:

  • Significant reduction in faculty preparation and administrative workload;
  • Real-time scoring that aligns directly with clinical learning objectives;
  • Objective student evaluations with built-in educational and remediation support;
  • Alignment with LCME (Liaison Committee on Medical Education) standards;
  • Secure and scalable exam delivery on campus or remotely.

The University of Minnesota has calculated its administrative cost savings of approximately 40 per cent. "Partnering with Treatment.com AI gave us the opportunity to explore how clinically governed AI can strengthen the way we assess and support student learning. The MES allowed us to deliver a high-stakes OSCE at scale while ensuring consistent, objective evaluation aligned with our academic standards. The MES represents a meaningful step forward in the evolution of medical education," said Prof. Claudio Violato, assistant dean, University of Minnesota Medical School. "We look forward to sharing our findings."

The MES combines AI-simulated patients with automated feedback, helping faculty assess diagnostic and management reasoning, clinical prioritization and documentation quality, all mapped to learning objectives. Early feedback suggests that the platform enhances the student learning experience and strengthens the reliability of OSCE results.

Preliminary results of the accuracy and precision of the GLM as applied in the MES platform were presented at the AAMC's (Association of American Medical Colleges) 2025 Group on Information Resources meeting. Prof. Violato, Dr. Peterson and their respective teams are preparing further scientific publications detailing the methodology, deployment and outcomes of the University of Minnesota program.

Treatment.com AI is engaging with a wide variety of other schools, with the goal to extend the MES offering across North America and the United Kingdom and to other international OSCE markets.

About Treatment.com AI Inc.

Treatment.com AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the health care sector and impact current inefficiencies and challenges. With the input of hundreds of health care professionals globally, Treatment.com AI has built a comprehensive, personalized health care AI engine -- the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all health care professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps health care professionals (doctors, nurses or pharmacists) reduce their administrative burden, creates more time for needed face-to-face patient appointments and enables greater consistency in quality of patient support. Treatment.com AI's GLM platform, through supporting health care professionals, allows for the inclusion of disenfranchised communities.

We seek Safe Harbor.

© 2025 Canjex Publishing Ltd. All rights reserved.